INS and Hyperglycemia: Additionally, Bai (25 mg/kg/d and 50 mg/kg/d) and GALR2 antagonist M871 (10 mg/kg/d) improved metabolic function in obese mice by reducing hyperglycemia and enhancing insulin sensitivity.